[Anti-inflammatory treatment of ankylosing spondylitis (author's transl)].
Anti-inflammatory treatment of ankylosing spondylitis is based on the administration of the various non-steroid anti-inflammatory agents made available since the introduction of phenylbutazone. As with this later compound they each have a group of patients that respond to their administration and are able to tolerate them. In this way, physical education exercises can be undertaken for the spine and chest several times a day, which is the only therapy capable of improving prognosis and avoiding stiffening and spinal deformities. A study protocol is proposed that has the advantage of allowing a rapid evaluation of the efficacy and tolerance of the products successively administered for short periods, by using scored evaluation criteria. The most effective and better tolerated compound for each patient can thus be determined. This protocol is valid for both general practice or therapeutic study use, and in open or double-blind trials.
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D008297:Male; D012107:Research Design; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents
La conduite du traitement anti-inflammatoire dans la spondylarthrite ankylosante.